Oxford Immunotec's Series E Round

Oxford Immunotec raised a round of funding on June 18, 2012.

Oxford Immunotec (NASDAQ:OXFD) is a global diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions. T-SPOT is the…

Articles about Oxford Immunotec's Series E Round: